asima 2019-08-19 17:50 IP:重慶
目前有4500+條ATC多編碼數(shù)據(jù)需要?jiǎng)澐种鞔侮P(guān)系(即一個(gè)藥對(duì)應(yīng)的主要或關(guān)鍵適應(yīng)癥排序,最主要最關(guān)鍵的適應(yīng)癥排在前面,其次依序排列),已將數(shù)據(jù)分為多個(gè)數(shù)據(jù)包,每個(gè)數(shù)據(jù)包里包含了200個(gè)左右的藥品通用名,500元一個(gè)數(shù)據(jù)包(必須在規(guī)定時(shí)間完成并保證高的準(zhǔn)確度)。 每人每次只可領(lǐng)取一個(gè)數(shù)據(jù)包,一個(gè)數(shù)據(jù)包的處理時(shí)間為3天。數(shù)據(jù)審核合格以后付款,完成優(yōu)秀者,可重復(fù)領(lǐng)取數(shù)據(jù)包。 人員要求: (1)藥學(xué)本科及以上學(xué)歷或有中級(jí)職稱; (2)英語水平較好; (3)精通ATC編碼或以前參與過藥智網(wǎng)西藥ATC分類,且完成工作較好者。 PS:此貼用于領(lǐng)取任務(wù),發(fā)布獎(jiǎng)金時(shí)在另行發(fā)布帖子由任務(wù)接收者單獨(dú)領(lǐng)取,完成質(zhì)量較好者會(huì)有額外獎(jiǎng)勵(lì)   [更多]
懸賞
¥400.00
已托管
載入中...
sssssssss 2019-08-08 11:04 IP:重慶
各位醫(yī)藥行業(yè)朋友,本公司提供實(shí)驗(yàn)室系統(tǒng)整體解決方案:包括實(shí)驗(yàn)室空間規(guī)劃設(shè)計(jì)、建設(shè)、裝修、潔凈、通風(fēng)系統(tǒng)、供氣系統(tǒng)、電波暗室、EMC測(cè)試系統(tǒng)、教學(xué)儀器設(shè)備、危化品智能控制系統(tǒng)、實(shí)驗(yàn)室管理系統(tǒng)等。現(xiàn)高價(jià)懸賞與我司業(yè)務(wù)相關(guān)項(xiàng)目需求信息,區(qū)域不限,只需提供信息,一經(jīng)核實(shí)立賞100元 信息格式如下: 企業(yè)、項(xiàng)目名稱:XXXX 項(xiàng)目負(fù)責(zé)人+聯(lián)系方式:XXXX 項(xiàng)目簡(jiǎn)述:XXXX 信息提供人+電話:XXXX 注:為防止征集項(xiàng)目重復(fù),請(qǐng)?jiān)诘谝淮瓮稑?biāo)填寫信息時(shí),只需要填寫企業(yè)、項(xiàng)目名稱,本司確認(rèn)不重復(fù)后,再行提交上述全部信息,在打電話核實(shí)屬實(shí)后,給予賞金兌現(xiàn)! 倘若成單,另有高額獎(jiǎng)勵(lì)!   [更多]
懸賞:
懸賞
¥1000.00
已托管
載入中...
Like2291 2019-08-05 13:38 IP:重慶
1、Effect of probenecid or diet on tebipenem pivoxil tablets pharmacokinetics in healthy male volunteers; 2、Effect of diet on the pharmacokinetics of tebipenem pivoxil fine granules in healthy male volunteers; 3、Pharmacokinetics analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infection 1、Pharmacokinetic properties of isosorbide-5-mononitrate under fasting and fed conditions in healthy male subjects. Jin C, Jeon JY, Im YJ, Jeong JA, Kim Y, Chae SW, Bentz J, Kumke T, Kim MG. 7.The control of myopia with atropine.   [更多]
懸賞
¥50.00
已托管
載入中...
Like2291 2019-08-02 11:39 IP:重慶
1.Myopia Control with Bifocal Contact Lenses:?A Randomized Clinical Trial 2.The Role of Atropine Eye Drops in Myopia Control 4. Myopia Control: A Review 7. Efficacy of 1%?atropine?eye drops in retarding progressive axial myopia in Indian eyes 8.Atropine?0.01% Eyedrops Significantly Reduce the Progression of Childhood Myopia 9.Current approaches to myopia control 10.Atropine?for the Prevention of Progression in Myopia - Data, Side Effects, Practical Guidelines 13. Atropine?0.01% Eyedrops Significantly Reduce the Progression of Childhood Myopia. 18. The treatment of myopia with?atropine?and bifocals. A long-term prospective study 19. Inhibitory effects of apomorphine and?atropine?and their combination on myopia in chicks 20. The penetration and distribution of topical?atropine?in animal ocular tissues. 21. Treatment outcomes of?myopic?anisometropia with 1%?atropine: a pilot study 23. Does?atropine?use increase intraocular pressure in?myopic?children? 24. Atropine?use for the prevention of myopia progression 25. Allergic reactions to?atropine?eye drops for retardation of progressive myopia in children. 29. Maximum?atropine?dose without clinical signs or symptoms. 31. Atropine?and bifocals can slow the progression of myopia in children. 33. Prevention of myopia onset with 0.025%?atropine?in premyopic children 35. The long-term results of using low-concentration?atropine?eye drops for controlling myopia progression in schoolchildren. 37. Prevention of myopia progression with 0.05%?atropine?solution.   [更多]
懸賞:
懸賞
¥100.00
已托管
載入中...
Steve_Olson 2019-08-01 16:24 IP:重慶
根據(jù)已知企業(yè)名稱(寫法不規(guī)范) 去CFDA http://app1.sfda.gov.cn/datasearchcnda/face3/base.jsp?tableId=25&tableName=TABLE25&title=%B9%FA%B2%FA%D2%A9%C6%B7&bcId=152904713761213296322795806604 或 藥智數(shù)據(jù)https://db.yaozh.com/pijian 查找對(duì)應(yīng)的規(guī)范企業(yè)名稱 無法確認(rèn)的需備注好原因 規(guī)范數(shù)據(jù)按照0.05元/條(10000條500元) 備注數(shù)據(jù)按照0.01元/條(10000條100元) 準(zhǔn)確率要求98%。   [更多]
懸賞
¥2880.00
已托管
載入中...
Like2291 2019-07-25 11:23 IP:重慶
1、P. A. Prajapati and M. M. Patel, “Formulation and in vitro evaluation of atropine sulphate viscous ocular solutions for the mydriatic and cycloplegic effect,”?International Journal of Pharmaceutical and Applied Sciences, vol. 1, no. 2, pp. 70–78, 2010.?View at Google Scholar 2、D. S. Satya, K. P. Suria, and P. P. Muthu, “Advanced approaches and evaluation of ocular drug delivery system,”?American Journal of PharmTech Research, vol. 1, no. 4, pp. 72–92, 2011.?View at Google Scholar 3、B. K. Nanjwade, D. B. Sonaje, and F. V. Manvi, “In vitro—in vivo?release of ciprofloxacin from ophthalmic formulations,”?International Journal of Pharmacy and Biotechnology, vol. 1, no. 1, pp. 23–28, 2011.?View at Google Scholar 4、Physicochemical properties and stability of nicorandil By Nagai, Hiroshi; Koizumi, Ikue; Haneda, Masatoshi; Imai, Toshikatsu; Kikuchi, Mineo; Shiba, Motoharu From Iyakuhin Kenkyu (1983), 14(6), 968-79. Language: Japanese, Database: CAPLUS 5、Sobean oil partially hydrogenated 最新德國(guó)藥典   [更多]
懸賞
¥50.00
已托管
載入中...
小驛 2019-07-11 14:25 IP:重慶
各位朋友,藥智谷主要為針對(duì)園區(qū)服務(wù),現(xiàn)有全國(guó)多個(gè)園區(qū)委托藥智谷招商,引入醫(yī)藥、大健康企業(yè)或項(xiàng)目,現(xiàn)高價(jià)懸賞醫(yī)藥項(xiàng)目信息,區(qū)域不限,只需提供信息,一經(jīng)核實(shí)立賞500元,懸賞以下類型項(xiàng)目信息: 1、醫(yī)藥健康類企業(yè)準(zhǔn)備對(duì)外建分廠、新公司,想尋找園區(qū)或找地方落地的; 2、醫(yī)藥健康類創(chuàng)業(yè)想入駐園區(qū)或找地方落地的; 3、醫(yī)藥健康類企業(yè)有想搬遷新址,還在尋找地方的; 信息格式如下: 企業(yè)、項(xiàng)目名稱:XXXX 項(xiàng)目投資負(fù)責(zé)人+聯(lián)系電話:XXX(187XXXX5133) 需求簡(jiǎn)述: 信息提供人+電話:XXX(187XXXX5133) 注意:為防止征集項(xiàng)目重復(fù),請(qǐng)?jiān)诘谝淮瓮稑?biāo)填寫信息時(shí),只需要填寫企業(yè)、項(xiàng)目名稱,藥智谷確認(rèn)不重復(fù)后,再行提交上述全部信息,在藥智谷打電話核實(shí)屬實(shí)后,給予賞金兌現(xiàn)!   [更多]
懸賞:
懸賞
¥5000.00
已托管
載入中...
likezwh 2019-07-08 15:03 IP:珠海
標(biāo)題:本公司擬并購中成藥生產(chǎn)銷售企業(yè) 詳細(xì)要求: 1、產(chǎn)品要求:必須有治療心腦血管、“三高”、代謝性疾病中成藥產(chǎn)品和批文。 2、銷售要求:心腦血管、“三高”、代謝性疾病中成藥產(chǎn)品銷售已進(jìn)入醫(yī)院,并具備一定市場(chǎng)份額。 3、企業(yè)成長(zhǎng)時(shí)間較長(zhǎng),有較好的歷史文人背景。 4、廠址以廣東省為主,其它省也可考慮。 5、如有保健食品產(chǎn)品和批文及生產(chǎn)線更佳。 6、廠區(qū)最好有預(yù)留生產(chǎn)車間或預(yù)留建筑用地。 7、提供擬轉(zhuǎn)讓企業(yè)負(fù)責(zé)人聯(lián)系方式,如確符合要求,可多人中標(biāo)。   [更多]
懸賞:
懸賞
¥100.00
已托管
載入中...
admin1111 2019-07-05 15:57 IP:南京
我們公司承接維生素系列一致性評(píng)價(jià)工作(維生素C注射液,維生素B2、B6注射液),希望能推薦有需要的客戶,聯(lián)系人以及聯(lián)系方式. 我公司承諾一致性評(píng)價(jià)不通過全額退款。   [更多]
懸賞
¥500.00
已托管
載入中...
Like2291 2019-07-03 15:59 IP:重慶
1.Arzneimittel Forschung/Drug research 1986 36(2),p291-303. 2.The use of antithrombotic drugs in artery disease 3. Jonassen IB, Havelund S, Ribel U, et al. Insulin Degludec is a new generation ultra-long acting basal insulin with a unique mechanism of protraction based on multi-hexamer ormation [J]. Diabetes, 2010, 59(Suppll): All(39-OR). 4.Korsatko S, Deller S, Zahiragic S, et al. Ultra-long-acting insulin degludec: two different formulations (U100 and U200) are bioequivalent and show similar pharmacodynamics [abstract no. 2349-PO]. Diabetes. 2011;60 Suppl:A624. 5.Technology Reports of the Osaka University, , vol. 7, p. 177,182。   [更多]
懸賞
¥50.00
已托管
載入中...
發(fā)布需求,坐等藥智客上門
  • 安全可靠,先驗(yàn)收再正式付款
  • 性價(jià)比超高,節(jié)省一半費(fèi)用
  • 80%的需求得到了圓滿解決
立即發(fā)布需求

推薦任務(wù)